You are here:

voriconazole (Vfend)

Advice

in the absence of a submission from the holder of the marketing authorisation

voriconazole (Vfend®) is not recommended for use within NHS Scotland.

Indication under review: Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: voriconazole (Vfend)
SMC Drug ID: 1014/14
Manufacturer: Pfizer Ltd
Indication: Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.
BNF Category:
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 10 November 2014

Back